Startups
Lorem Cytori is a specialty therapeutics company focused on addressing significant unmet medical and market needs with cell therapy platforms.
Cytori Cell Therapy for scleroderma associated hand dysfunction, prepared using the Celution instrument and consumable set, is one of Cytori’s lead product candidates. Cytori Cell Therapy is also being studied for thermal burns, hip osteonecrosis, knee osteoarthritis, and stress urinary incontinence in the US and Japan.
Cytori Cell Therapy for scleroderma associated hand dysfunction, prepared using the Celution instrument and consumable set, is one of Cytori’s lead product candidates. Cytori Cell Therapy is also being studied for thermal burns, hip osteonecrosis, knee osteoarthritis, and stress urinary incontinence in the US and Japan.
Overview
Location
United States, California, San Diego
Employees
11-50
Total raised
$27M
Founded date
1997
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 13, 2014 | Cytori Completes $13.5M Registered Direct Offering | Cytori Therapeutics Inc. announced that it has completed the sale of shares of its Series A 3.6 percent convertible preferred stock pursuant to a registered direct offering representing gross proceeds of about $13.5 million. The preferred s... |
| Feb 13, 2014 | Former Wisconsin Gov. Thompson Wants to Form Angel Fund | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Former Wisconsin governor Tommy Thompson has aspirations for starting an early-stage investment fund—that’s if he can achieve a few exits this year with his current personal i... |
| Jul 1, 2013 | Cytori Gets $27M In Loan | San Diego-based Cytori Therapeutics announced this morning that it has entered into a $27M, term loan, from Oxford Finance Corporation and Silicon Valley Bank. The biotechnology developer, which is developing treatments for cardiovascular d... |
| Mar 19, 2012 | HeartWare lands FDA OK for extended trial ahead of PMA review | Regulatory Roundup | HeartWare lands approval for a 4th round of pivotal trials for its HVAD ventricular assist device HeartWare International (NSDQ:HTWR) won the FDA’s okay to add 54 patients to a pivotal U.S. trial of its ventricular assist system as a bridge... |
| Dec 7, 2011 | Avedro lands orphan status for corneal ectasia treatment | Regulatory Roundup | Avedro Inc. won an orphan drug designation for a solution used with its KXL irradiation system to treat corneal ectasia following refractive surgery. The decision sets the Waltham, Mass.-based company up for 7 years of exclusive rights to t... |
Reviews 0
FAQ about Lorem Cytori USA, Inc
When was Lorem Cytori USA, Inc founded?
Lorem Cytori USA, Inc was founded in 1997.
How much funding has Lorem Cytori USA, Inc raised?
Lorem Cytori USA, Inc has raised $27M in total across 1 funding round.
What has the press written about Lorem Cytori USA, Inc?
Parsers VC has collected 6 articles mentioning Lorem Cytori USA, Inc, among them “Cytori Completes $13.5M Registered Direct Offering” (Oct 13, 2014) and “Former Wisconsin Gov. Thompson Wants to Form Angel Fund” (Feb 13, 2014).
Is Lorem Cytori USA, Inc still active?
Yes, Lorem Cytori USA, Inc is active; its latest activity on Parsers VC dates from Jul 9, 2018.